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ARTICLE
Structural basis of the membrane intramolecular
transacylase reaction responsible for lyso-form
lipoprotein synthesis
Samir Olatunji 1, Katherine Bowen 2, Chia-Ying Huang 3, Dietmar Weichert 1, Warispreet Singh4,5,6,
Irina G. Tikhonova 4, Eoin M. Scanlan2, Vincent Olieric 3 & Martin Caffrey 1✉
Lipoproteins serve diverse functions in the bacterial cell and some are essential for survival.
Some lipoproteins are adjuvants eliciting responses from the innate immune system of the
host. The growing list of membrane enzymes responsible for lipoprotein synthesis includes
the recently discovered lipoprotein intramolecular transacylase, Lit. Lit creates a lipoprotein
that is less immunogenic, possibly enabling the bacteria to gain a foothold in the host by
stealth. Here, we report the crystal structure of the Lit enzyme from Bacillus cereus and
describe its mechanism of action. Lit consists of four transmembrane helices with an
extracellular cap. Conserved residues map to the cap-membrane interface. They include two
catalytic histidines that function to effect unimolecular transacylation. The reaction involves
acyl transfer from the sn-2 position of the glyceryl moiety to the amino group on the N-
terminal cysteine of the substrate via an 8-membered ring intermediate. Transacylation takes
place in a confined aromatic residue-rich environment that likely evolved to bring distant
moieties on the substrate into proximity and proper orientation for catalysis.
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A quarter of all proteins in Escherichia coli arelipoproteins1. Some of these are enzymes, others areinhibitors or components of complexes responsible for
cell envelope biogenesis, nutrient uptake and detoxification. E.
coli’s most abundant protein, Braun’s lipoprotein, secures the
outer membrane and the peptidoglycan layer together2. By virtue
of being essential or virulence factors, the enzymes responsible for
lipoprotein synthesis are important targets for the development of
antibiotics to treat a growing number of drug resistant bacteria3,4.
Relatedly, higher organisms have developed an alert system to
respond to bacterial infections that is triggered by lipoproteins5,6.
These are potent agonists of Toll-like receptors (TLRs) that, when
activated, set in motion sequential innate and acquired immune
responses eventually leading to the production of neutralising
antibodies. In this capacity therefore, bacterial lipoproteins
(BLPs) function as natural adjuvants7,8. Indeed, BLPs have been
used as such in a number of vaccines9,10. They can also be
included in vaccine formulations as potent antigens11. Clearly,
lipoproteins deserve our attention for the myriad functions they
serve in the life of the bacterial cell and their hallmark signature
as ‘other’ or ‘foreign’ duly responded to by the immune system.
Until recently, the canonical pathway of BLP posttranslational
processing in Gram-negative organisms included three enzymes
(Fig. 1). All reside in the cytoplasmic membrane and all have
active sites facing the periplasm. The first enzyme, lipoprotein
diacylglyceryltransferase, Lgt, transfers a diacylglyceryl (DAG)
moiety from a phospholipid, usually phosphatidylglycerol, PG, to
a conserved cysteine in the membrane-anchored signal peptide of
a preproBLP12. The lipid and the protein are in thioether linkage
and the modification produces a proBLP that is now doubly
anchored in the membrane. The second enzyme is lipoprotein
signal peptidase II, LspA13–16. It removes the signal peptide from
the proBLP by cleaving to the N-side of the cysteine and generates
a DAG-modified BLP as product. This diacylated BLP (DA-BLP)
is acted on by a third enzyme, lipoprotein N-acyltransferase, Lnt,
which N-acylates the free amino group of the lipidated cysteine in
the DA-BLP thereby generating a triacylated BLP (TA-BLP)
product17–20. The localisation of lipoprotein, Lol, system of pro-
teins then shuttles the TA-BLP to the outer membrane for
directed partitioning between its inner and outer leaflets21. The
source lipid for the Lnt reaction is predominantly phosphatidy-
lethanolamine, PE. It is the acyl chain at the sn-1 position on the
glyceryl moiety of PE that is transferred. While DA-BLPs activate
the TLR2/TLR6 system, TA-BLPs are TLR2/TLR1 system
agonists6,22,23.
In 2012, Kurokawa et al.24, identified three BLP variants based
on mass spectrometric (MS) analyses of lipoproteins from Gram-
positive firmicutes known to lack Lnt sequence orthologs. They
included BLPs with an acetyl and a dipeptide in amide linkage to
the N-terminal cysteine. The third variant was a lyso-BLP, so
named because it has just one acyl chain in ester linkage to the
glyceryl moiety attached to the N-terminal cysteine and a second
acyl chain in amide linkage to its α-amino group (Fig. 1). It was
proposed then that the enzyme responsible for lyso-BLP synthesis
was either a transacylase which transfers one of the acyl chains
from the DAG of DA-BLP to the α-amino group of the N-
terminal cysteine. Alternatively, it was an O-deacylase which
cleaves an acyl chain from the DAG of TA-BLP generated by an
unidentified Lnt-like activity24. On the basis of an intergenic
complementation rescue assay, the membrane integral enzyme
responsible was identified in 2017 as likely having the former
activity22. The enzyme was shown to be chromosomally encoded
in low-GC Gram-positive bacteria and was named lipoprotein
intramolecular transacylase, Lit. Which of the two acyl chains in
the DAG that is transferred was not known although some data
available at the time suggested it was the sn-2 chain. Nor indeed
was the mechanism of transfer known. Speculation included an
acylated enzyme intermediate and a direct transfer reaction.
Work reported here, and recently by Armbruster et al1., favour
the latter mechanism.
In 2019, Armbruster et al., identified a second lit, lit2, on a
mobile genetic element in certain strains of the Gram-positive
bacteria, Listeria monocytogenes and Enterococcus spp23.
Expression of lit2 was shown to be tightly regulated. It was
induced by copper and was co-transcribed with a second lgt (lgt2)
and several copper-resistance determinants. The original
chromosome-encoded Lit, from here on referred to simply as Lit
(Bacillus cereus, 218 residues), and Lit2 (L. monocytogenes, 204
residues) have analogous primary structures with sequence
identities and homologies of 27 and 50%, respectively. They have
similar enzymatic activities and their lyso-BLP products are
considerably weaker ligands of the TLR systems than either DA-
BLP or TA-BLP22,23.
In the space of 8 years therefore, an additional class of cysteine-
modified lipoproteins and the enzymes responsible for their
synthesis have been identified. An intriguing link to copper
homoeostasis in bacteria and to immune response attenuation
raises interest in these lipoprotein processing enzymes.
In this work, we report the high-resolution crystal structure of
Lit from B. cereus with a view to understanding how the enzyme
Fig. 1 Bacterial lipoprotein cysteine-based post-translational modification
pathways. a Preprolipoprotein is converted to (b) prolipoprotein by the
action of Lgt which uses PG as the lipid substrate. G1P is the second
product of the reaction. Prolipoprotein is cleaved by the signal peptidase II,
LspA, generating (c) apo-lipoprotein and signal peptide. In Gram-negative
bacteria, Lnt N-acylates the apo-lipoprotein using PE forming (d) triacylated
lipoprotein and lyso-PE. In low-GC% Gram-positive bacteria such as B.
cereus and E. faecalis, Lit performs an intramolecular transacylation on apo-
lipoprotein forming (e) lyso-lipoprotein. Lipoprotein interactions with
receptors, TLR2/1 and TLR2/6, are indicated in c–e. A different type of
lipoprotein, where processing involves signal peptidase I cleavage and
acylation at an N-terminal glycine, has been described recently39,40.
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functions at a molecular level. Combined with a direct functional
assay, analytical nuclear magnetic resonance (NMR) spectro-
scopy, mutagenesis, molecular dynamics simulations (MDS) and
quantum mechanics/molecular mechanics (QM/MM), a model
for how the enzyme carries out intramolecular transacylation
emerges with insights into substrate selectivity.
Results
Lit structure. B. cereus is a Gram-positive facultative anaerobic
bacteria that lives on food and in soil25. In humans, it is
responsible for foodborne illnesses that include severe diarrhoea
and vomiting. It is used as a probiotic in the diet of chickens, pigs
and rabbits. A hexahistidine N-terminally tagged variant of Lit
from B. cereus was over-expressed in E. coli and was crystallised
by the in meso method with monoolein as the host lipid26,27. Two
structures were solved; one at 2.27 Å, the other at 1.95 Å (Sup-
plementary Table 1). The former, in space group P21, displayed
type I crystal packing (Supplementary Fig. 1). The latter, in space
group P21212, had a packing that is less obviously type I that may
have emerged as a result of a polymorphic transition from a
nascent crystal with type I packing28. Both structures have two
similar molecules in the asymmetric unit. Root mean-square
deviations calculated for Cα atoms in the different structures (211
to 216 residues) range from 0.21 to 0.40 Å. Here, we focus on
molecule B (MolB) in the 1.95 Å structure, which has the better
quality electron density.
The protein assumes the shape of a truncated cone that spans
the membrane with four transmembrane helices (M1–M4)
(Fig. 2). Its wider end extends into the extracellular space. The
narrower part is embedded in the membrane. Very little of the
protein, that includes both N- and C-termini, extends into
the cytoplasm. Consistent with the positive inside rule, this end of
the protein is richly cationic. The protein has a pseudosymmetry
between its N- and C-terminal halves. The N-terminal half
consists of a membrane domain (MD1) and an extracellular
globular domain (EGD1). MD1 includes two membrane helices
(M1 and M2). M1 and M2 are linked by EGD1 consisting of three
helices (H1–H3) and three turns of the M2 helix that extend
beyond the membrane. The corresponding parts of the C-
terminal half include a membrane domain (MD2) with two
membrane helices (M3 and M4), and a globular domain (EGD2)
with two helices (H4 and H5) and two turns of the M4 helix that
reside in the extracytoplasmic space. H1 and H4 are amphiphilic
and are expected to sit, in part or entirely, on the membrane
surface. Monoolein molecules from the mesophase in which
crystallogenesis occurs coat the protein surface recapitulating the
native membrane and occupy a volume inside the protein. We
assume these internal lipids take the place of lipoprotein substrate
and product acyl chains, as discussed below. The pseudosym-
metry between the structure of the N- and C-terminal halves of
Lit is not obvious in their sequences.
The two central helices, M2 and M3, of the membrane-
embedded domain are connected at the intracellular side by a
short loop. They splay apart in the shape of a V as they cross the
membrane. The N- and C-terminal membrane helices, M1 and
M4, straddle the base of the V. This results in the four TM helices
forming a tight bundle toward the intracellular side of the
membrane. Viewed from the cytoplasm, these four helices are
arranged quite symmetrically about the loop connecting M2 and
M3 (Supplementary Fig. 2). As the four TM helices cross the
membrane, they fan out forming a hemi-cylinder, the concave
surface of which is exposed to the membrane interior and is
decorated with hydrophobic residues. The hemi-cylinder, which
roughly resembles a four fingered hand, has helices, M3, M4, M1
and M2 (fingers on the hand) arranged from left to right in that
order (Fig. 2). The fingertips of M2 and M4 extend out of the
membrane into the extracellular space. The extracellular end of
the hemi-cylinder is covered by a dome-shaped cap domain (CD)
which, in turn, is composed of EGD1 and EGD2. The shape
complementarity between EGD1 (groove, concave) and EGD2
(bulge, convex) where they meet is striking. EGD1 creates a large
concave pocket into which sits the convex shaped EGD2.
Interactions between the two are predominantly hydrophobic.
The dome-shaped CD has a hydrophobic interior surface. It
extends away from the fan of transmembrane helices with its
convex apolar surface facing down toward the membrane. In so
doing, it creates an opening from the membrane into the apolar
dome interior below the amphiphilic H4. Based on a Dali
search29, the structural fold observed in Lit has not been reported
previously. It is stable in a membrane as judged by MD
simulations (Supplementary Fig. 3 and Supplementary Movie 1).
A homology model of Lit2 from L. monocytogenes is remarkably
similar to the template Lit crystal structure from B. cereus
(Supplementary Fig. 4).
Putative active site. Sequence analysis identified several highly
conserved residues in Lit that include His85, Val89, Phe149,
His153, Phe157 and Trp162 (Supplementary Table 2 and Sup-
plementary Fig. 5). Conserved residues have stood the test of
evolutionary time because they serve a role in catalysis, in folding
and/or structural stability. They all map onto the dome-shaped
structure that sits atop the transmembrane helices in the extra-
cytoplasmic space of the apoprotein (Fig. 3). We assume therefore
that this is where the active site of the protein resides. This makes
functional sense given that this same orientation, with the active
site toward the extracytoplasmic interface of the membrane, is
adopted by the three other lipoprotein processing enzymes, Lgt,
LspA and Lnt15,18,30. It is also where the substrate’s DAG-
modified cysteine is expected to situate15. Notably, two structured
monoolein molecules that derive from the crystallisation process
reside with their glyceryl head groups coordinated with the two
conserved histidines (Fig. 3 and Supplementary Fig. 6). These
lipids are considered surrogates of the DAG moiety of the DA-
BLP substrate and serve to reinforce the view that they sit
proximal to the active site of Lit. Of the conserved residues, His85
and His153 are the only ones with polar and potentially charged
side chains of the type typically found as catalytic residues31.
They are within 5 Å of one another and are situated in the protein
at the level of or slightly above the membrane interface. They are
surrounded by aromatics (Phe86, Phe145, Phe149, Phe152,
Phe157, Trp162, Phe164 and Phe180) several of which are highly
conserved (Supplementary Fig. 7, Supplementary Table 2 and
Supplementary Movie 1). Thus, stabilising π-stacking as well as
cation–π interactions between the two histidines and neigh-
bouring aromatics is possible regardless of the protonation state
of either or both histidines32. For now, we assume His85 and
His153 constitute the catalytic dyad in Lit that functions as a
monomer. Evidence supporting this view comes from MD and
QM/MM simulations and from structure-based site-directed
mutagenesis, described below. An evaluation of the mutagenesis
work was enabled by the development of a direct method for
quantifying Lit transacylase activity.
Transacylase assay. Lit catalyses a transacylation reaction in
which there is but one lipoprotein substrate and one lipoprotein
product. The molecular changes that occur during the reaction
include the conversion of an ester and an ammonium group to a
hydroxyl group and an amide (Fig. 1). We reasoned that the slight
polarity difference between the substrate and product might be
exploited such that they could be separated and quantified by thin
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layer chromatography (TLC) provided the molecular weights
involved were not too great. To facilitate visualisation, the lipo-
protein substrate was labelled with a fluorophore (FP2) (Sup-
plementary Fig. 8). FP2 has a DAG-modified cysteine at the
N-terminus followed by two serines and a C-terminal lysine with
the fluorophore, 2-aminobenzoyl (Abz), in amide linkage to its
ɛ-amino group. By optimising TLC mobile phases, one was
identified that cleanly separated the Lit substrate and product.
Both are visible by fluorescence on the TLC plate and can be
quantified by image analysis. NMR spectroscopy was used to
identify the product and to show that the acyl chain at the sn-2
position on the glyceryl of the substrate is transferred in the Lit
reaction (vide infra).
This simple TLC assay based on FP2 provides a convenient and
direct method for quantifying Lit activity. With it, conditions for
performing activity-based assays were established (Supplemen-
tary Figs. 9 and 10). The enzyme was shown to be inactive with
the (S)-stereoisomer of the DAG in the substrate and, by
extension, specific for the (R)-stereoisomer. It was optimally
active in the pH range from 4.4 to 5.4. Subsequent assays were
Fig. 2 Overall architecture of apo-Lit from B. cereus. a View from the membrane plane into the active site from the front. Substrate and product putatively
enter and leave the active site via a fenestration (arrowhead) that opens between the extracyctoplasmic halves of M3 and M4. Structured lipids in the
active site pocket have grey and purple carbon atoms for clarity. Approximate location of catalytic residues, His85 and His153, are marked with yellow stars
on M2 and H4, respectively. Monoolein molecules that coat the surface of the protein have been omitted for clarity. Approximate location of the
membrane boundaries are shown as horizontal lines. b View from the membrane plane into the active site from the back. c View from the extracellular
space into the active site. Fenestration marked with an arrowhead. d Topology of Lit in a simplified representation to highlight the elements of symmetry in
the protein. e A view of the protein from the back with helices shown as rods. f The pseudo twofold structural symmetry in Lit, illustrated by dividing the
protein into N- and C-terminal halves (transparent blue and red), can be seen by comparing e and f which are in the same orientation. MD and EGD
correspond to the membrane domain and the extracellular globular domain, respectively.
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usually performed at 37 °C for 30 min in a buffer containing
25 mM MES/NaOH, pH 5.4, 0.2 M sodium chloride, 0.02%(w/v)
LMNG, 0.15 mM FP2 and 10 µM Lit. Under these conditions, the
enzyme had an apparent turnover number of ~0.25 mole of
substrate per min per mole of Lit.
As part of the characterisation of Lit as an enzyme, its
sensitivity to divalent cations was examined (Supplementary
Fig. 10). To begin with, activity was determined in the presence of
EDTA which was shown to have no effect. This suggested that
cations, at inhibitory concentrations, were not present in the
enzyme preparation and that divalent cations may not be
required for catalysis. Subsequent assays were performed in the
presence of calcium, magnesium, zinc and copper. Neither
calcium nor magnesium had any effect on activity. However,
conversion of substrate to product was reduced considerably by
zinc and was stopped completely by copper.
Fig. 3 Location and mutational analysis of conserved residues demark putative active and substrate binding sites in Lit. a Structure of Lit with
conserved residues colour coded from blue to purple corresponding to low and high % conservation, respectively. b Sequence logo74 representation of a
Clustal Omega71 sequence alignment of 788 Lit orthologs from the UniProt Reference Proteomes database68. c View from the membrane at the eight
conserved residues (purple carbons) in Lit that are assumed to define the substrate-binding pocket. The pocket resides at and above the surface of the
membrane (black bars). Conserved residues are at ≥90% conservation. d A zoomed in view of the conserved residues in Lit from which internal lipids have
been removed. Red lettering denotes highly conserved residues (≥98% conservation). e A zoomed in view of the conserved residues in Lit along with the
structured monoolein molecules that co-crystallise with the enzyme. Electron densities that define the lipid molecules are shown in Supplementary Fig. 6.
The lipids are considered surrogates for the diacylglyceryl chains in the lipoprotein substrate. Distances shown as dashed lines are in ångströms.
f Transferase activity of Lit mutants. Values are expressed as a percentage of wild-type (WT). A TLC assay was used to quantify Lit activity with FP2 as
substrate on the basis of a 30min incubation at 37 °C. The standard deviation is calculated on the basis of duplicate measurements. Mutants of the
putative catalytic residues H85 and H153 are highlighted for clarity.
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Given that copper is implicated in Lit2 upregulation23, we
further investigated the effect of copper on Lit. It seemed
plausible that copper could inhibit the enzyme given that its
putative active site residues include a pair of proximal histidines
which might bind copper. An alternative hypothesis was also
considered that copper might coordinate with the lipopeptide
substrate23 in which form it is no longer processed by Lit. Thus,
assays were performed at increasing concentrations of copper
(0–1 mM) under conditions where the enzyme (0.01 mM) and
substrate (0.15 mM) concentrations were held constant (Supple-
mentary Fig. 10c, d). Copper had no effect on activity until its
concentration rose to 0.05 mM and above. No activity was
observed at 0.3 mM copper and above. These results suggest that
copper does not affect the enzyme directly. Rather, that it binds to
the substrate, which in complex with copper is no longer
converted to product. It has been proposed that BLPs of form
DA-BLP, by virtue of having an amino group and sulphur (and
oxygen) atoms in close proximity in the terminal cysteine, can
directly bind copper23. Exploratory NMR measurements show
that copper does indeed interact with the N-terminus of the
lipopeptide substrate (Supplementary Figs. 11–14).
Evaluating the role of select residues in Lit action. With the
transacylation assay in place and optimised, the proposed
mechanism of Lit action with His85 and His153 as the catalytic
dyad and the role of other conserved residues were tested using
purified mutant enzyme (Fig. 3f). That His85 and His153 play a
role in catalysis was evaluated by preparing mutants from His to
Ala, Asn, Asp, Gln, Glu and Arg at each position. Of the 12
mutants, only His85Asp failed to express. The remaining five
His85 mutants expressed protein, however they were without
significant activity consistent with this residue playing a role in
catalysis. Four of the His153 mutants (Ala, Asn, Gln and Arg)
likewise were inactive. However, His153Asp and His153Glu had
27 and 77% of wild-type activity, respectively. These results
suggest that His153 is the second residue that functions alongside
His85 in a general acid–base transacylase reaction mechanism, as
proposed1. Thus, His85 would remain protonated throughout the
reaction while His153 (and His153Asp and His153Glu) would be
free to engage in protonic equilibrium. As discussed below,
His85Ala and His85Arg were crystallised in the presence of the
FP2 substrate and structures of both mutant forms were obtained.
These observations indicate that His85 is not essential for the
expression, folding or stability of Lit. That His85 remains fully
protonated through the reaction is supported by its observed
hydrogen bonding with structured lipid MO1 and with structured
Water1 that, in turn, interacts with Asp88 and Asn159 (Supple-
mentary Fig. 7). QM/MM data also support this conclusion
(Supplementary Figs. 15 and 16).
Phe157 is the most highly conserved residue in Lit. It sits on
the loop connecting H4 and H5 facing into the active site
equidistant from and just below catalytic His85 and His153
(Supplementary Fig. 7a). Given that Phe157 is essentially
invariant, the fact that the Phe157Ala construct is inactive comes
as no surprise. However, it is not clear what role this residue
plays. It may be that the charge distribution and π electrons in its
phenyl ring interact functionally with nearby His85 and His153
(and presumably with His153Asp and His153Glu)32 to facilitate
the Lit reaction. It may also play a role in orienting the substrate
optimally for binding and for reaction. The fact that it expressed
well and behaved as normal during purification suggests that
Phe157 is not essential for folding or stability. MD simulations
and QM/MM calculations show that Phe157, along with other
local aromatic residues, through interactions with catalytic
histidines and with substrate, intermediates and product, likely
plays a role in facilitating the transacylation reaction (Supple-
mentary Tables 3 and 4).
Lys90 sits on M2 at the level of the extracytoplasmic membrane
facing away from the active site (Supplementary Fig. 17). In
orthologs, arginine often takes its place suggesting that a cationic
side chain is important at this position. In Lit, Lys90 interacts
closely with backbone carbonyls in the turn just after amphiphilic
H3 and with the helix dipole in H3. It likely contributes to
stabilising part of the extramembrane dome above and to one side
of the active site. Not unexpectedly, the Lys90Ala mutant is
essentially inactive (Fig. 3f).
We have speculated that the extramembrane domain, with its
internal apolar surface, is an important functional feature of Lit.
We tested this hypothesis by mutating Leu59 and Phe86, both of
which contribute to the hydrophobic surface, to polar residues.
Leu59Asn was inactive while Phe86Thr retained just 18% of wild-
type activity. Both substitutions were with residues approximately
equal in size to the original but they differed in polarity. The
results are consistent with the need for a dome with an apolar
inner surface for full activity. Altering this feature likely adversely
affects how the substrate engages with the enzyme.
This targeted mutational study reinforces the view that the
active site of the enzyme is made up of the highly conserved
residues His85, His153 and Phe157 and that the apolar under-
surface of the CD is an important feature of the substrate-binding
pocket.
Lipoprotein substrate binding. The lipoprotein substrate and
product of Lit have two acyl chains attached to an N-terminal
cysteine. In the substrate, the chains are next to one another
esterified to neighbouring hydroxyls on the glycerol backbone. In
the product, one chain is on the glycerol while the other is
attached to the α-amino group of the cysteine. Presumably, these
two quite distinct arrangements of acyl chains on the cysteine are
accommodated in the active site pocket of the enzyme. How this
might happen is suggested by the way in which two structured
lipid molecules sit in the putative binding pocket of the apoen-
zyme (Fig. 3). These are monooleins that derive from the host
mesophase used for crystallogenesis.
The two monooleins reside with their head groups below the
interior apolar surface of the dome domain on the extracyto-
plasmic side of the membrane (Supplementary Fig. 18). MO1 sits
higher up in the dome with its head group above the plane of the
membrane interface. MO2 is seated lower down; its head group
sits at about the level of the membrane interface next to MO1.
The sn-2 hydroxyl of MO1 coordinates with His85. The sn-3
hydroxyl of MO2 coordinates with His85 and His153. Their acyl
chains extend away from the dome into the apolar recesses of the
membrane in various ways reflecting the flexible nature of
hydrocarbon chains. In MolB of the asymmetric unit, the chains
run parallel to one another below the apolar surface of
amphiphilic H4. In MolA, they splay apart with one below H4
as in MolA and the other extending out of the binding pocket to
contact M3 within the membrane. Because the two acyl chains
originate as ester linkages some distance from one another in the
two monooleins, our interpretation is that these structured lipids
more closely resemble the acyl chains in the Lit lipoprotein
product than they do its substrate. However, we have used the
orientation and conformation of MO1 and MO2 to provide a
basis for how the lipoprotein substrate and product might be
placed in the binding pocket for reaction and for use in the
computational studies described below (Supplementary Fig. 19).
The primary hydroxyl of MO1 extends toward and can be seen
through the opening in the dome of apo-Lit. It coordinates with a
structured water (Wat2) that sits in the centre of the opening
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(Supplementary Fig. 18). This suggests that the peptide tether
between the diacylated cysteine and the folded domain of the
lipoprotein may well extend through this same opening. The
dome has a hemispherical shape and an apolar internal surface.
Thus, any entity such as a diacylated cysteine to which is attached
a polar peptide tether, that enters the dome as proposed, will
likely rise within the dome to position its polar parts above the
level of the membrane interface. This presumably would place the
sn-2 oxygen of the lipoprotein substrate’s glyceryl moiety next to
the catalytic histidine dyad for reaction. Because the enclosing
apolar surface has a concave shape, those parts of the diacylated
cysteine that might normally be distant in a less confining space
will be cinched together to become proximal within the dome.
Thus, the dome may have evolved to bring the donor sn-2 ester
moiety of the DAG and the acceptor α-amino group on the
cysteine into close proximity and alignment for reaction. The (R,
R) stereochemistry at the DAG-modified cysteine undoubtedly
facilitates optimal substrate presentation also.
With a view to establishing how Lit interacts with its substrate,
attempts were made to obtain a crystal structure of an inactive
form of the enzyme bound to the lipopeptide substrate, FP2, used
for acyltransferase assay work. The His85Ala and His85Arg
mutants were chosen for complex formation since both were
essentially inactive with this substrate. The cubicon method33 was
used to form the complex in the cubic mesophase as a prelude to
crystallogenesis of His85Ala. Crystals and structures were
obtained with both mutants. However, while density that could
possibly be identified with the substrate was observed with the
two mutants, it was not reliably fit with the lipopeptide as model
(Supplementary Fig. 20). Our conclusion therefore is that the
density observed in the substrate-binding pocket of these two
constructs corresponds to structured monoolein molecules.
In the apo form of Lit, M3 is bent midway along its length
between Pro134 and Pro140 (Fig. 3). At the front of the bend that
faces into the membrane is a structured water, Wat89. This water
molecule is coordinated by backbone carbonyls of Ile135 and
Ala136 and by the backbone amide of Leu139 with reasonable
tetrahedral interaction geometry (107.7°, 83.0° and 117.2°). Thus,
Wat89 provides compensating hydrogen bonds broken as a result
of the bend and, in so doing, stabilises the bend. In the His85Ala
and His85Arg mutant structures obtained with crystals grown in
the presence of the lipopeptide substrate, a different kink appears
in M3 that causes it to curve away from M4 (Supplementary
Fig. 20c). Deviation from a straight helix is no doubt aided by
Gly126, Pro134 and Pro140 in this helix. Interestingly, a water
molecule, Wat2 in His85Ala, stabilises the kink through hydrogen
bonds with the backbone carbonyls of Ala14 and Thr130 and the
amide of Phe18. Curvature in M3 is such that it separates from
M4 toward its extracellular end to a greater extent than seen in
wild-type Lit (Supplementary Fig. 21). In so doing, it acts as a gate
to create an opening between the two helices that leads into the
putative active site. The fenestration extends into the dome
providing a conduit at least 10 Å wide along its length presumably
for both the polar peptide and apolar lipid parts of the lipopeptide
substrate and product to move into and out of the binding pocket.
MD simulations support this view (Supplementary Fig. 22 and
Supplementary Movies 2–4).
The particular ‘open’ conformations captured in the inactive
constructs likely reflect the fact that the catalytic residue, His85,
has been mutated to non-conservative residues (Supplementary
Fig. 21). These Ala for His substitutions interfere with the tight
packing and strong π–cation and π–π interactions of conserved
aromatic residues in and around the active site of the native
enzyme. Indeed, in both mutants aromatics that include Phe149,
Phe152, Phe157, His153 and Trp162 have rearranged in a manner
that may facilitate opening the M3 gate. Thus, while these mutant
forms are not physiologically relevant, the structures they adopt
may reveal features, such as the open gate, that are functionally
relevant.
Reaction mechanism. One of the goals of this investigation was
to establish the mechanism of the Lit reaction responsible for the
production of lyso-BLPs in low-GC Gram-positive firmicute
bacteria. Two mechanisms have been proposed1,24 (Supplemen-
tary Fig. 15). One involves transfer of an acyl chain from the
DAG of DA-BLP to the enzyme and thence to the free N-terminal
amino group to form lyso-BLP. The other is an intramolecular
shift of the chain to the free amino group of DA-BLP. To date, no
direct evidence for either of these mechanisms has been provided.
Indeed, until very recently, which of the two acyl chains on the
DAG that is transferred remained unknown. These and related
mechanistic issues were addressed in the following studies.
Glycerophospholipids are synthesised in bacteria beginning
with the (R)-enantiomer of glycerol-3-phosphate34. Thus, the
DAG in lipoproteins is expected to be of the (R)-stereochemical
form. This hypothesis was tested in the current study with
stereochemically pure (R)- and (S)-lipopeptide substrates as used
in the transacylase assay (Supplementary Fig. 8). Lit showed no
product formation after extensive incubation with the (S)-
lipopeptide. However, with the (R)-form the enzyme converted
~70% of the substrate to product in 30 min at 37 °C (Supple-
mentary Fig. 9b–d). This result shows that the enzyme is
stereoselective and is specific for the (R)-lipopeptide substrate.
To establish which of the two chains is transferred in the
course of the Lit reaction, a synthetic lipopeptide substrate
incorporating a mixed chain DAG was used. Specifically,
protiated and perdeuterated acyl chains were positioned,
respectively, at the sn-1 and sn-2 positions of the glyceryl moiety
(Supplementary Fig. 8). Hereafter, the mixed chain substrate is
referred to as dFP2. Apart from being deuterated, dFP2 is
identical to the protiated FP2 substrate used for all other work,
including activity assays, reported in this study. The enzyme was
incubated with dFP2 under standard assay conditions and the
reaction was allowed to proceed for 18 h to maximise product
(lyso-dFP2) formation. Substrate and product were separated by
preparative TLC and the product band was collected, extracted
and the extract used for NMR (Supplementary Figs. 23–26).
An analysis of the 1H−13C heteronuclear single quantum
coherence (HSQC) and total correlation spectroscopy (TOCSY)
NMR data (Supplementary Figs. 27–34) show that the oxygen at
C2 of the glyceryl moiety in the monoacylglyceryl of the lyso-
dFP2 product is no longer acylated and exists as a secondary
hydroxyl. At the same time, the amide in the lyso-dFP2 product
links the amino group of cysteine to the perdeuterated acyl chain.
Further, measurements with lyso-FP2 show that the sn-2 position
was no longer acylated and that a protiated acyl chain was part of
the amide linkage in the lyso-FP2 product. These data prove that
the acyl chain transferred by Lit comes from the sn-2 position
of the DAG in the BLP substrate. A similar conclusion was
reached by Armbruster et al1. on the basis of MS analysis of a
recombinantly produced lipoprotein containing deuterated acyl
chains in the DAG moiety.
To further explore the reaction catalysed by Lit, QM/MM
calculations were performed to evaluate proposed transacylation
mechanisms. The first calculation considered the nucleophilic
mechanism which involves formation of a transient acylated
enzyme intermediate (Supplementary Fig. 15a). The simulation
was set up with His85 and His153 as catalytic residues. To
simulate the first step in the reaction, the epsilon nitrogen atom of
His153 was moved closer to the carbonyl carbon atom of the
substrate sn-2 chain to form the N-C bond of the acylated
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intermediate. However, the potential energy scan showed no
evidence of intermediates nor of transition states. In addition, the
energy cost of the process was unrealistically high35, in excess of
25 kcal/mol, which implies that the reaction is kinetically
inaccessible (see Methods). For these reasons and because acyl-
histidine intermediates are rare36, the proposed mechanism was
discounted. Indeed, the only time histidine dyads function as
nucleophiles is in phosphotransferases, where the histidines
interact directly with one another31. It might also be argued that
acylating the enzyme creates a monoacylated lipopeptide and that
a single chain may not be enough to keep the intermediate stably
in place. If formed, it may partition out of the enzyme’s binding
pocket. Indeed, MD simulations show that the monoacylated
lipopeptide interacts weakly with residues in the enzyme
(Supplementary Table 3).
The alternative, general acid–base mechanism was evaluated by
invoking His153 as the nucleophile. It abstracts a proton from the
free α-ammonium group of the DAG-modified cysteine in the
DA-BLP substrate (Fig. 4, Supplementary Figs. 15b and 16,
Supplementary Table 5 and Supplementary Movies 5–7). The
newly formed amine attacks the carbonyl carbon at the sn-2
position of the DAG forming an eight-membered heterocyclic
intermediate with a tetrahedral carbon and a tetrahedral nitrogen.
The negative charge on the oxygen bonded to the tetrahedral
carbon is stabilised by the proximal His85 which remains
protonated throughout the reaction. A deprotonated His85 next
to the cyclic intermediate does not allow the reaction to proceed
(Supplementary Fig. 16). The positive charge on the heterocycle
nitrogen repels the imidazolium side chain of His153 causing it to
rotate away from the active site toward the aqueous phase where
it is stabilised by π–cation interaction with conserved Trp162
(Supplementary Movie 6). Collapse of the cyclic intermediate
gives rise to the uncharged lyso-BLP product with its resonance-
stabilised trans amide bond. The amide linkage, with its affinity
for hydrogen bond donors and acceptors, associates with two
water molecules (Supplementary Fig. 35). The need to more fully
Fig. 4 Proposed mechanism of the Lit intramolecular transacylation reaction. (Inner panels). The general acid–base mechanism invokes His153 as the
nucleophile which abstracts a proton from the free α-ammonium group of cysteine in the DA-BLP substrate. The newly formed amine (intermediate 1, IM1),
attacks the carbonyl carbon at the sn-2 position of the DAG forming an eight-membered heterocyclic intermediate with tetrahedral carbon and nitrogen
atoms (intermediate 2, IM2). The negative charge on the oxygen bonded to the tetrahedral carbon is stabilised by the proximal His85 which remains
protonated throughout the reaction. Collapse of the intermediate gives rise to the lyso-BLP product (P). Deprotonation of His153 by equilibration with bulk
water restores the enzyme to its original form in preparation for another round of reaction. Transition state structures (TS1, TS2 and TS3) are shown in
square brackets. TS3 includes a transient four-membered ring containing carbon, nitrogen, hydrogen and oxygen atoms that is stabilised presumably by
local bonded and non-bonded interactions. (Outer panels) 3D structures of complexes between Lit and reactant, transition states, intermediates and
product derived from QM/MM. The eight-membered heterocyclic intermediate (IM2) adopts a chair-like conformation (inset), which was maintained
throughout the MD simulations. The acylated cysteine is shown with cyan carbon atoms. The catalytic histidines have green carbons. Polar and hydrogen
bond interactions are shown as dashed lines with distances in ångströms. Dashed lines in the transition states represent forming and breaking partial
bonds. The bond between the carbon and the non-bridging oxygen in the sn-2 acyl chain is identified by a black line.
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hydrate undoubtedly contributes to the driving force for the
product to depart the binding pocket. The last step in the reaction
is the deprotonation of His153 which occurs by facile protonic
equilibration with bulk water (Supplementary Fig. 15b). This is
accompanied by the return of the imidazole side chain of His153
to face into the binding pocket restoring the enzyme to its original
form for another round of reaction (Supplementary Movie 7).
The energy cost associated with this reaction pathway was 21.7
kcal/mol (Supplementary Fig. 15b), which means that the direct
mechanism is thermodynamically feasible37. It corresponds to a
rate constant of 0.19 min−1 which agrees well with the
experimental apparent turnover number of 0.25 min−1. The
concurrence lends credence to the proposed general acid–base
mechanism.
Discussion
The work presented here was performed using heterologously
expressed and detergent solubilized protein. The structural
information was obtained with the enzyme confined to a crystal
lattice. By contrast, related studies of Lit by Kurokawa et al.24, and
by the Meredith group1,22 were carried out, for the most part,
with whole cells. Satisfyingly, the crystal structure matches and
rationalises many of the observations made with the protein in its
more natural in vivo setting. These include the membrane
topology of the protein with its four transmembrane helices,
intracellular N- and C-termini, and extracellular loops in which
reside the catalytic histidines. Indeed, the rationalisation extends
to the difficulty in the whole cell work of localising the domains in
which the catalytic residues are found. This makes sense because
EGD2, which includes His153, is flexible with amphiphilic
H4 sitting at the membrane interface. This flexibility is corro-
borated by the high crystallographic B-factors in this part of the
protein and by MDS analysis (Supplementary Fig. 3 and Sup-
plementary Movie 2). Further, alanine-scanning mutagenesis
applied to E. faecalis Lit alleles in E. coli, with cell growth rescue
as readout, identified a set of residues that map remarkably well
to those in the substrate-binding pocket and active site identified
on the basis of the crystal structures1. This agreement between
whole cell and pure protein work lends credence to the physio-
logical relevance of the current findings.
It is worth considering why it is necessary in certain organisms
to convert DA-BLP to lyso-BLP and by extension, why Lit is
necessary? Another way to pose the question is, What is it that a
lyso-BLP does that its DA-BLP counterpart cannot? The question
is particularly relevant in the case of Gram-positive bacteria
which lack an outer membrane. Such organisms do not have a
requirement for Lnt and TA-BLP formation for trafficking via the
Lol system as applies in the case of Gram-negative bacteria. Given
the compositional make-up of the Lit substrate and product, it
cannot be the identity of the fatty acyl chains that distinguishes
them because the Lit reaction simply moves one of the chains on
the DAG to the amino group of the N-terminal cysteine. Perhaps
however the shift alters the relative orientation, depth of pene-
tration, partitioning and/or mobility of the substrate and product
in the membrane (Supplementary Fig. 36). These differences may,
in turn, influence the activity of the lipoprotein. The effect could
be to toggle activity between on and off states or to more gra-
dually modulate the lipoprotein’s activity level. An argument
against this being a reversible switch must reference thermo-
dynamics. The amide linkage in the product, lyso-BLP, is con-
siderably more stable than the ester in the substrate, DA-BLP.
This is borne out experimentally in that wild-type E. faecalis cells
were found to have little detectable DA-BLP; the vast majority of
the cell’s BLPs existed in the more stable lyso-BLP form22. Thus,
once formed lyso-BLP does not revert to a DA-BLP. And any
change in activity as a result of transacylation is irreversible.
For whatever reason Lit came to exist, it has the advantage over
Lnt and the recently discovered LnsAB38 and AatD39,40, the only
other known amino terminus acylating enzymes, that upon
reaction it does not produce a lyso-phospholipid (lyso-PL) as a
second product1. Lyso-PLs, as the name implies, are potent sur-
factants that, at high enough concentrations, will effectively
punch holes in and eventually solubilise membranes. A million
copies of Braun’s lipoprotein reside in the cell wall of E. coli, all
processed through Lnt2. Simultaneous with lipoprotein synthesis,
an equal number of lyso-PLs is produced. A typical cell has an
estimated 20 million PLs in each leaflet of the inner membrane.
The newly formed lyso-PL will therefore appear in the outer
leaflet of the inner membrane at high (5 mol%) concentration. If
nothing is done to remove this powerful detergent, the integrity of
the membrane would be compromised with fatal consequences
for the cell. Fortunately, repair systems are in place that shunt
lyso-PLs back into benign diacyl-PLs41,42. No such repair system
exists in Gram-positive bacteria which means that an Lnt-type
activity, with lyso-PL as a product, could not be tolerated. It
makes sense therefore that Gram-positive organisms, with a need
for N-acylated lipoproteins, should have evolved Lit activity.
Because the reaction catalysed by Lit is intramolecular, additional
substrates and products are not involved, making for an efficient
route to N-acylated lipoproteins.
Copper is an essential trace element. Beyond a certain con-
centration however this transition metal becomes toxic43. Copper
is approved for public health use as an antibacterial agent espe-
cially for sterilising touch surfaces. Its application as a growth-
promoter in the diet of food-producing animals has raised con-
cerns for possibly contributing to the rise in antimicrobial
resistance44. In host/pathogen relationships, the toxic properties
of copper have been exploited. Infected macrophages, for exam-
ple, store copper in phagosomes to combat Staphylococcus aureus.
In turn, bacteria have evolved defence mechanisms that employ
copper transporters, chaperones and oxidases. These copper-
detoxification features are typically found in mobile genetic ele-
ments as plasmids or islands in chromosomal DNA. They con-
tribute to the facile development of strains resistant to copper and
to elimination by the host immune system. lit2 is part of a
copper-sensitive operon. Its expression, upon exposure to copper,
coincides with the upregulation of copper-resistance genes23. As
noted, Lit2 expression will lead to the conversion of DA-BLP to
lyso-BLP. In so doing, a potent agonist of the innate defence
system’s TLRs is converted to the much more benign lyso-BLP.
This immunity attenuating response, presumably works in con-
cert with the suite of newly expressed copper-resistance genes to
enable the invading organism to fend off attack by the host, and
to survive and multiply. Recently, CopL, a lipoprotein in S. aur-
eus, has been shown to bind copper ions with attomolar affinity45.
CopL has been speculated to play a role in resisting copper killing
and in binding excess copper pumped from the cell by efflux
proteins. DA-BLPs may function likewise to sequester piped
copper. Copper binding proteins may also act as a reserve in
times of copper deficiency.
In the absence of experimental proof that Lit transfers the sn-2
and not the sn-1 chain from the DAG to the free amino group of
DA-BLP, the same conclusion could perhaps have been reached
based on a simple inspection of the unimolecular transacylation
reaction. The reaction passes through a heterocyclic intermediate.
If it is the chain at sn-1 that gets transferred, an intermediate with
a nine-membered ring forms. By contrast, it is an eight-
membered ring that forms when transfer is from the sn-2 posi-
tion (Fig. 4). Different sized rings are characterised by different
strain energies46. That for a nine-membered ring, at least in the
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case of cycloalkanes, is strained to the extent of 2–3 kcal/mol
more than its eight-membered counterpart. For this reason alone,
and considering the behaviour of carbocycles in particular, it was
predictable that the transfer catalysed by Lit involved the sn-2 and
not the sn-1 as the acyl chain donor site. Relatedly, the cyclooc-
tanoid is a motif common to several therapeutically important
natural products and is noted for its conformational flexibility.
The boat-chair conformation is the most stable. While total
synthesis of compounds that include eight-membered rings is
experimentally challenging, Lit would appear to have evolved a
way of doing so facilely in a reaction vessel some cubic nano-
metres in volume that is the active site pocket of the enzyme.
Indeed, lessons in total synthesis might usefully be gained by
inspecting the form of and the chemical constellation that con-
stitutes this highly evolved nanospace.
By two orders of magnitude, lyso-BLPs are less potent TLR
agonists than DA-BLPs or TA-BLPs23. Thus, Lit may have
evolved to enable organisms evade detection and clearing by the
host by converting DA-BLP to the more benign lyso-BLP. This
would enable bacteria, endowed with Lit, to gain a foothold by
stealth by not hyper-activating the innate immune alert system.
Thus, Lit may be viewed as a virulence factor and a target for
antibiotic development47. Resistance pressure and the likelihood
of resistance development are much reduced in the case of a non-
essential functionality as with Lit. A therapeutic that blocked Lit
activity would therefore cause DA-BLPs to accumulate which, in
turn, would activate the immune systems to clear the infection.
Based on assays performed with nonimmune HEK-Blue-TLR2/
1/6 reporter cells using synthetic and native BLPs, lyso-BLPs have
been shown to interact preferentially with the heterodimeric
TLR2/TLR6 as opposed to the TLR2/TLR1 receptor pair23. This
finding was unexpected in light of earlier crystal structure and
functional studies showing DA-BLP and TA-BLP binding to and
signalling at the TLR2/6 and TLR2/1 receptor systems,
respectively48,49. Thus, the DAG chains in the two BLPs were
accommodated in the large binding pocket of TLR2 while the N-
acyl chain of TA-BLP was located in the smaller binding pocket
of TLR1. TLR6 remained empty in its complex with TLR2 and
DA-BLP. However, from our crystal structure and modelling
studies, the two chains in lyso-BLP can come into close contact
adopting a side-by-side conformation as might be expected for
adjacent chains in a DAG. This would explain how the two chains
in the lyso-BLP can bind with TLR2. It may be that the inter-
actions in this compact TLR2/TLR6 complex are energetically
more favourable than might apply with the two chains spayed
apart, one in TLR1 and the other bound to a half empty TLR2, in
the TLR2/TLR1 pair. Regardless of the strength of the interaction,
the potency of lyso-BLP TLR signalling is reduced by two orders
of magnitude compared to the DA- and TA-BLPs.
Methods
Cloning and site-directed mutagenesis. The wild-type lit gene from B. cereus
strain ATCC 14579 (Uniprot ID: Q813T3_BACCR) was codon optimised for
expression in E. coli cells and commercially synthesised (GenScript, USA). The
synthetic gene was amplified by polymerase chain reaction (PCR) using amplifi-
cation primers listed in Supplementary Table 6. The resulting PCR product was
digested by the restriction enzymes NdeI and XhoI, and ligated into the NdeI/XhoI
digested pET28MHL plasmid (GenBank accession number EF456735). The
resultant pET28MHL-lit plasmid encodes for B. cereus Lit protein carrying a M-
H6-SSGRENLYFQGH N-terminal extension.
Lit mutants were obtained by site-directed mutagenesis using the Q5® Site-
Directed Mutagenesis Kit (New England Biolabs, UK), the wild-type pET28MHL-
lit construct as template, and specific primers listed in Supplementary Table 6. All
constructs were verified by sequencing (Eurofins Genomics, Germany).
Expression and purification of Lit. E. coli C43(DE3) cells (Lucigen) carrying the
pET28MHL-lit plasmid were grown in Terrific Broth medium supplemented with
50 μg/mL kanamycin at 37 °C and 180 revolutions per minute (rpm) (Infors HT
Multitron incubator shaker) to an optical density at 600 nm (OD600) of 0.5–0.7. At
this point, the temperature was reduced to 20 °C, and the gene expression was
induced with 0.6 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). After over-
night growth for 16–18 h at 20 °C, cells were harvested by centrifugation at 6000×g
for 10 min at 4 °C (rotor F10S-6x500y), and the resulting pellets were resuspended
in 0.3 g/mL of Buffer A (25 mM HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol,
5 mM MgCl2, 2%(w/v) DNAse, final pH 7.5). Cells were disrupted by four passages
at 20,000 p.s.i and 4 °C through a high-pressure homogeniser (Emulsiflex-C5,
Avestin®). Cell debris was removed by centrifugation at 30,000 × g for 30 min at
4 °C and the supernatant was ultracentrifuged at 150,000 × g for 90 min at 4 °C
(rotor Ti-45). The membrane pellet was resuspended in 10 mL of Buffer B (25 mM
HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol, 1.5%(w/v) lauryl maltose neo-
pentyl glycol (LMNG), final pH 7.5) per gram of wet membranes and solubilised
for 16 h at 4 °C on a Nutator mixer (VWR). Insoluble material was removed by
ultracentrifugation at 150,000×g for 30 min at 4 °C. The supernatant was supple-
mented with 10 mM imidazole and mixed with 3 mL of TALON® Metal Affinity
Resin (Clontech Laboratories, Inc.) pre-equilibrated with Buffer C (25 mM HEPES/
NaOH, 200 mM NaCl, 10%(v/v) glycerol, 0.02%(w/v) LMNG, final pH 7.5). After
incubation for 4 h at 4 °C, the suspension was poured into an empty 1.5 × 12 cm
Econo-Pac® chromatography column (Bio-Rad). The resin was washed with 25 mL
of Buffer D (25 mM HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol, 0.02%(w/v)
LMNG, 20 mM imidazole, final pH 7.5), 25 mL of high-salt Buffer E (25 mM
HEPES/NaOH, 500 mM NaCl, 10%(v/v) glycerol, 0.02%(w/v) LMNG, 20 mM
imidazole, final pH 7.5) and 25 mL of Buffer D. After additional washes with Buffer
D containing increasing concentrations of imidazole (10 mL at 40, 60 and 80 mM),
the protein was eluted in 6 mL of 1 M imidazole in Buffer D. The eluted protein
was further purified by size exclusion chromatography (SEC) using a HiLoad 16/60
Superdex 200 column (GE Healthcare) pre-equilibrated with Buffer F (25 mM
HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol, 0.02%(w/v) LMNG, final pH
7.5). The purified protein was concentrated to ≥12 mg/mL with a 50 kDa molecular
weight cut-off (MWCO) concentrator (Amicon® Ultra, Millipore). Aliquots of the
purified protein were flash-frozen in liquid nitrogen and stored at −70 °C.
Expression and purification of Lit wild-type and mutant proteins for enzyme
assays were performed as described above except that the buffer used for SEC was
Buffer G (25 mM Tris/HCl, 80 mM NaCl, 10%(v/v) glycerol, 0.02%(w/v) LMNG,
final pH 8.3).
For selenomethionine (SeMet) labelling, cells were grown in M9 minimal
medium to an OD600 of 0.6. Methionine biosynthesis was suppressed50 by adding
100 mg/L of Lys, Phe and Thr, 50 mg/L of Ile, Leu and Val and 60 mg/L of L-SeMet.
After 15 min, lit gene expression was induced with 0.4 mM IPTG for 18 h at 20 °C.
Purification of SeMet-labelled Lit was performed as described above for the
native, wild-type protein with the following modifications. The cell lysis and
membrane solubilisation buffers were supplemented with 2 mM DTT, 1 mM PMSF
and a tablet of cOmpleteTM EDTA-free protease inhibitor cocktail per 50 mL of
buffer. The detergent extract was supplemented with 10 mM imidazole and mixed
with 5 mL of nickel-charged resin (Ni-NTA agarose, Qiagen) pre-equilibrated with
Buffer H (25 mM HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol, 2 mM DTT,
1 mM PMSF 0.05%(w/v) LMNG, cOmpleteTM EDTA-free protease inhibitor
cocktail (1 tablet/50 mL), final pH 7.2). After incubation at 4 °C for 4 h, the resin
was washed twice with 50 mL of Buffer H containing 20 and 30 mM imidazole. The
protein was eluted with 30 mL of Buffer H containing 600 mM imidazole and
concentrated to 10 mL using a 50 kDa MWCO concentrator. The buffer was
exchanged to Buffer I (25 mM HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol,
5 mM β-ME, 0.05%(w/v) LMNG, final pH 7.2) using PD10 desalting columns (GE
healthcare). A second affinity chromatography purification was performed by
supplementing the protein with 10 mM imidazole and incubating it with 3 mL of
TALON Metal Affinity Resin for 12 h at 4 °C. The resin was washed with 25 mL of
high-salt Buffer J (25 mM HEPES/NaOH, 500 mM NaCl, 10%(v/v) glycerol, 5 mM
β-ME, 0.05%(w/v) LMNG, 20 mM imidazole, final pH 7.2) and 10 mL Buffer I
containing 40 mM imidazole. The protein was eluted in 3 × 10 mL of Buffer I
containing 500 mM imidazole. The elution fractions were pooled, concentrated to
1.8 mL and subjected to SEC on a HiLoad 16/60 Superdex 200 column equilibrated
with 25 mM HEPES/NaOH, 200 mM NaCl, 10%(v/v) glycerol, 0.05%(w/v) LMNG,
2 mM TCEP, final pH 7.2. The purified SeMet-labelled protein was concentrated to
15.6 mg/mL for use in crystallisation trials.
Protein quantitation. The concentration of Lit wild-type and mutants proteins
was determined with a Nanodrop-1000 spectrophotometer (Nanodrop Technolo-
gies, Wilmington, DE, USA) using the molecular weights and extinction coeffi-
cients at 280 nm calculated with the ExPASy ProtParam tool51.
Peptide synthesis. Lit substrates FP2, (S)-DAG-FP2 and dFP2 were prepared by
manual 9H-fluoren-9-ylmethoxycarbonyl/tert-butyl (Fmoc/tBu) solid phase pep-
tide synthesis (SPPS) on Rink amide resin. The initial resin was Fmoc-deprotected
using 20%(v/v) piperidine/N,N-dimethylformamide (DMF) for 2 × 10 min. Load-
ing of the first amino acid was performed with Fmoc-Lys(Nε-4-methyltrityl)-OH
(4 equiv), benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate
(PyBOP) (4 equiv) and N-methylmorpholine (NMM) (8 equiv) in DMF for 45 min.
On-resin introduction of the fluorophore, Abz, to the lysine side chain was
achieved via 4-methyltrityl deprotection with 5%(v/v) trifluoroacetic acid (TFA),
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5%(v/v) triethylsilane (TES) and 90%(v/v) CH2Cl2 for 5 × 1 min followed by
coupling of Boc-Abz-OH (3 equiv) with PyBOP (3 equiv) and NMM (6 equiv) in
DMF for 45 min. To complete the assembly of each peptide on-resin, iterative
cycles of Fmoc deprotection using 20%(v/v) piperidine/DMF for 2 × 10 min and
coupling of Fmoc-amino acid (3 equiv) with PyBOP (3 equiv) and NMM (6 equiv)
in DMF for 45 min were carried out. Peptides were subsequently cleaved from the
resin and fully deprotected upon treatment with 95%(v/v) TFA, 2.5%(v/v) TES and
2.5%(v/v) H2O for 90 min. Final peptides were precipitated in Et2O and purified by
normal phase silica gel column chromatography. Further synthetic details with
compound characterisation are provided in the Supporting Information.
Modified cysteine building blocks, Fmoc-Cys((S)-2,3-bis(palmitoyloxy)propyl)-
OH and Fmoc-Cys((R)-2-((hexadecanoyl-d31)oxy)-3-(palmitoyloxy)propyl)-OH
were synthesised as described in the Supporting Information.
TLC-based activity assay. The activity of Lit was assayed in 50 µL of reaction
mixture containing 150 µM FP2 in assay buffer (25 mM MES/NaOH pH 5.4, 200
mM NaCl, 0.02%(w/v) LMNG). The lipopeptide was added from a stock solution
at 10 mg/mL (9.1 mM) in dimethyl sulfoxide (DMSO). The reaction was initiated
by adding 10 µM Lit and was carried out at 37 °C without shaking. The reactions
were stopped after the indicated time by flash freezing in liquid nitrogen.
To aid extraction of the lipophilic peptide substrate and product from the
reaction mix, 50 µL of 70%(v/v) ethanol was added to the frozen reaction mix
samples, followed by vortexing for 10–20 s at 20 °C until an homogenous emulsion
was obtained. Lipophilic substrate and product were extracted by vortexing 30 µL
of chloroform with the emulsion for 60 s. Phase separation was facilitated by
centrifugation in a benchtop centrifuge for 2 min at 13,000×g and 20 °C, and the
lower chloroform phase was transferred into a 1.5-mL Eppendorf tube. The tube
was left open in a fume hood for 10 min at 20 °C to passively evaporate excess
chloroform. The tube was centrifuged for 2 min at 13,000×g and 20 °C, and all of
the collected organic phase was spotted on a silica gel 60 F254 TLC plate (Sigma
Aldrich). The plate was placed in a desiccator at 20 °C under high vacuum (50
mbar) for 10 min to remove residual DMSO. Chromatography was carried out with
a mobile phase consisting of CHCl3:MeOH:28% NH4OHaq (8:2:0.1 by vol.) and the
substrate and the product were directly visualised on the TLC plate under UV light
at 254 nm through quenching of the fluorescence indicator in the TLC plate by the
Abz moiety. A digital image of the UV-illuminated TLC plate was taken using a
smartphone, and the substrate and product band intensities were quantified by
image analysis using ImageJ52. The results were plotted using Prism 8 (GraphPad).
Lyso-FP2—NMR analysis. NMR spectroscopy was used to confirm the identity of
the Lit product. Several Lit reactions were set using a total of 100 and 500 µg of
protiated (FP2) or deuterated (dFP2) substrate, respectively, to generate enough
material for NMR analysis. The reactions were incubated at 37 °C for 18 h and
stopped by flash-freezing in liquid nitrogen. The substrate and product were
extracted as described above and separated on a preparative silica gel TLC plate
(Sigma Aldrich). The product was recovered by scraping the silica from the plate
with a clean spatula and washing it twice with CHCl3:MeOH (19:1, v/v). The
washings were combined and the silica pelleted by centrifugation 1000xg for 2 min.
The supernatant was collected and the solvent was evaporated under a stream of
nitrogen. The product was thoroughly dried in vacuo. Following preparative TLC,
each isolated product (lyso-FP2 and lyso-dFP2) was dissolved in DMSO-d6 (0.6
mL). NMR spectra were recorded on a 600MHz Bruker Avance II spectrometer
equipped with a 5 mm TCI CryoProbe operating at a frequency of 600.13 MHz (1H
NMR) or 150.6 MHz (13C NMR) at 25 °C. HSQC and TOCSY NMR experiments
were carried out to aid in structure elucidation (Supplementary Figs. 23–34). NMR
data was analysed using MestReNova v6.0.2–5475.
Copper–dFP2 interaction—NMR analysis. A solution of CuSO4.5H2O (0.023 mg,
0.0915 mol) in DMSO-d6 (60 µL) was added to a solution of dFP2 (1.00 mg, 0.915
µmol) in DMSO-d6 (600 µL). The sample was mixed, and NMR data was collected
and analysed as described above for the lyso-FP2 product.
Crystallisation. Crystals of wild-type native and SeMet-substituted Lit were
obtained by mixing the protein at 12–16 mg/mL with monoolein (NuChek) in a 2:3
protein:lipid volume ratio using the twin-syringe mixing method26,53. Aliquots of
30 nL of protein-laden mesophase were spotted on 96-well glass sandwich plates
and overlain with 800 nL of precipitant solution using a Gryphon LCP (Art
Robbins Instruments) or a Xantus (SIAS) crystallisation robot54. The plates were
stored at 20 °C in a crystallisation incubator (RUMED® 3101, Rubarth Apparate
GmbH, Germany) or in an incubator/imager (Rock Imager® 1500, Formulatrix,
USA) for crystal growth. Crystals typically appeared within 24 h and grew to full
size in 2 weeks. Monoclinic P21 crystals grew in a precipitant solution composed of
100 mM sodium citrate/HCl, pH 5.6, 40%(v/v) polyethylene glycol (PEG) 400, 100
mM ammonium sulfate and 200 mM sodium formate. The plate-shaped crystals
measured up to 400 µm in length. Orthorhombic P21212 crystals, rod-shaped and
measuring 10 × 10 × 50 µm3, grew in a precipitant solution composed of 100 mM
sodium citrate/HCl, pH 5.5, 75–150 mM NaCl and 36–44%(v/v) PEG 200.
For co-crystallisation trials with the substrate (R)-DAG-FP2, purified Lit H85A
and H85R mutant proteins were diluted to 2 mg/mL in Buffer G, mixed with a
fivefold molar excess of (R)-DAG-FP2 in DMSO, and incubated for 16–20 h at 4 °C
on a Nutator mixer (VWR) or a rotator (SB3, Stuart®, UK) circulating at 8 rpm.
For the H85A mutant, the cubicon method33 was used to concentrate the
protein-peptide mixture in the cubic mesophase. After 5 to 7 rounds of
reconstitution, the equivalent starting protein concentration was 12–14 mg/mL.
For the H85R mutant, the protein-peptide solution was concentrated to 15 mg/mL
with a 0.5-mL concentrator (50 kDa MWCO, Amicon® Ultra, Millipore) and mixed
with monoolein in a 2:3 protein:lipid volume ratio. LCP crystallisation plates were
set as described above for the wild-type protein. Crystals of the H85A mutant
were obtained in a precipitant composed of 100 mM sodium citrate/HCl, pH 5.5,
75–150 mM NaCl and 36–44%(v/v) PEG 200. In contrast, crystals of the
H85R mutant grew in a precipitant composed of 100 mM MES/NaOH, pH 6.0,
125–200 mM lithium citrate tribasic tetrahydrate and 36–44%(v/v) PEG 400. For
both mutants, monoclinic C2 crystals appear within 24 h and grew to a maximum
dimension of 20 × 60 µm2 in 2 weeks.
Crystals were harvested from the lipid cubic phase using Dual Thickness
MicroLoops LD or MicroMounts loops (MiTeGen), and snap-cooled and stored in
liquid nitrogen without added cryo-protectant. The in meso in situ
macromolecular X-ray crystallography (IMISX) method was used to grow and to
collect data on SeMet-labelled Lit crystals55.
Diffraction data collection and processing. X-ray diffraction experiments were
carried out at 100 K on protein crystallography beamlines X06SA-PXI at the Swiss
Light Source, Villigen, Switzerland, and I24 at the Diamond Light Source, Didcot,
UK. Measurements were made in steps of 0.1–0.2° at speeds of 1–2° per s with
either the EIGER 16M or the PILATUS 6M-F detector operated in a continuous/
shutterless data collection mode. For SeMet SAD phasing, diffraction data were
collected on SeMet-derivative B. cereus Lit (Lit-Se) crystals using both rotation and
serial crystallography methods55 at wavelength and flux values of 0.97882 Å and
1012 photons per s, respectively. Native data from wild-type Lit (Lit_1, Lit_2) and
mutant form (LitH85A, LitH85R) crystals were all measured using the rotation
method at wavelengths and flux values of 0.9686 Å and 4.1 ×−1012 photons per s,
respectively. The data set for Lit-Se crystals was measured with a 20 × 10 μm2 X-ray
beam size at beamline X06SA-PXI. Native data sets from Lit_1, Lit_2, LitH85A and
LitH85R crystals were measured with a 20 × 20 μm2 X-ray beam size at beamline
I24 DLS. Data were processed with XDS56 for Lit-Se and LitH85R with a resolution
cut-off at I/σ(I) of 1. For Lit_1, Lit_2 and Lit_H85A, the data sets were processed
using autoPROC/STARANISO57,58 with the resolution cut-offs applied based on
ellipsoidal diffraction limits. All of the data were scaled and merged with
XSCALE56. A SeMet derivative data set to 3.2 Å was obtained by merging the data
from 16 single crystals with 360° per crystals using the data acquisition software
suites (DA+)59 and 143 small wedge data of IMISX crystals with 10−20° per
crystals using an automated collection programme60 available at X06SA-PXI. Data
sets for Lit_1, Lit_2, LitH85A and LitH85R were collected from single crystals with
360° wedges to 2.27, 1.95, 2.43 and 2.20 Å resolution, respectively. Data collection
parameters are summarised in Supplementary Table 1.
Structure solution and refinement. The SAD method was employed for structure
solution using data sets from Lit-Se crystals. A substructure with CCall/weak values
of 44.36/16.51 was obtained with 10,000 SHELXD trials using the HKL2MAP61
interface of SHELXC/D/E. Additional phase improvement and iterative auto-model
building were carried out with CRANK262 using the substructure from SHELXD,
the Lit sequence and a high-resolution native data set obtained with Lit_1 crystals.
The Lit model with two molecules in the asymmetric unit was fully built auto-
matically by CRANK2 and was manually adjusted using Coot63. The structures of
Lit_2, LitH85A and LitH85R were obtained using Phaser64 with chain A of Lit_1 as
the searching template. Phenix.refine65 and BUSTER66 were used during the
refinement of all structures. Phasing and refinement statistics are reported in
Supplementary Table 1. Figures of molecular structures were generated with
PyMOL67.
Sequence conservation analysis. Sequences homologous to Lit were retrieved
from the UniProt Reference Proteomes database68 using the HmmerWeb
server69,70. The E value cut-off was set to 0.0001, and other parameters were kept to
their default values. The search converged after six iterations, and 788 sequences
were retrieved and aligned with Clustal Omega71. Conservation scores were cal-
culated using the Consurf server72,73 and mapped on the Lit crystal structure using
Pymol67. Sequence logo was produced using the WebLogo3 server74. A phyloge-
netic tree was constructed in MEGA X75 using the neighbour-joining method76.
MD and QM/MM simulations
System preparations for MD simulations. The crystal structure of Lit (MolB) at 1.95
Å resolution was used as an initial structure for MD simulations. The MD sub-
strate, Cys-Ser-Ser-Lys, with the cysteine residue attached to a dipalmitoylglyceryl
(R-stereoisomer) group was built using Maestro 2018–4 in the Schrodinger soft-
ware suite77. The structure of Lit with two monoolein molecules in the vicinity of
catalytic His85 and His153 provided a good starting point for substrate docking.
After removing the structured monooleins and water molecules from the Lit
structure, the MD substrate was placed into the active site with the sn-2 chain
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toward the catalytic histidines. The substrate-Lit complex was then subjected to a
short energy minimisation using Maestro 2018-477. The product-Lit complex was
generated by removing the sn-2 chain from the substrate DAG and linking it via an
amide bond to the α-amino group of cysteine. The product complex was also
energy optimised in Maestro 2018-477. Similarly, the Lit complex with lipopeptide
monoacylated at the sn-1 position was created from the substrate-Lit complex. The
structures of intermediate 1 (IM1) and intermediate 2 (IM2) complexes were
obtained from the QM/MM study. The force field parameters for the substrate,
product, monoacylated lipopeptide, IM1 and IM2 were developed in the Ante-
chamber programme of AmberTools1878 using the GAFF force field79.
The protonation states of titratable residues at pH 7.0 were predicted using the
PROPKA programme80 available in Maestro 2018-477. Aspartate, glutamate,
arginine and lysine residues were assigned a negative or a positive charge, as
appropriate. Non-catalytic histidine residues were modelled as neutral, with a
hydrogen atom bound to either the delta or epsilon nitrogen depending on which
tautomeric state optimised the local hydrogen-bonding network. Protonation states
of catalytic His85 and His153 were assigned taking into consideration their local
environment, QM/MM, and mutagenesis data. The side chain of His153 was in the
neutral form with a proton at the delta nitrogen in the MD simulations of Lit
bound to substrate and to monoacylated lipopeptide, and in the empty form.
His153 was in the charged imidazolium form in MD simulations of Lit bound to
the product and in the IM1 and IM2 states. Initial exploratory simulations were
performed with His85 in positively charged and neutral forms. His85 in the
charged form was chosen for the final MD simulations because the QM/MM
analysis showed that the eight-membered heterocyclic intermediate (IM2) of the
transacytlation reaction can only form in the presence of protonated His85.
Six Lit biosystems were used in this study. They include the empty form (where
the two structured monoolein molecules have been removed from the active site
pocket), substrate-, product- and monoacylated lipopeptide-bound forms, and IM1
and IM2 states in a hydrated lipid bilayer. These were constructed to study enzyme
dynamics and the reaction mechanism. The lipid bilayer consisted of 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG) in a 3:1 mole ratio. The position of the Lit
molecule across the lipid bilayer was established using the Orientation of Protein in
Membranes (OPM) server81. The CHARMM-GUI Lipid Builder82 was used to
insert the Lit structure into the lipid bilayer consisting of 120 lipid molecules in
each leaflet of the membrane. TIP3P water molecules83 were used to solvate the
bilayer and counterions were added using Monte Carlo simulations at a
concentration of 0.15M NaCl. The final systems comprised ~88,000 atoms with a
box dimension of 95 × 95 × 100 Å3.
MD simulations protocols. All MD simulations were performed using the Compute
Unified Device Architecture (CUDA) version of particle-mesh Ewald molecular
dynamics (PMEMD) in Amber1878,84,85 on graphics processing units (GPUs). All
systems were subjected to energy minimisation using the steepest descent
(1000 steps) followed by the conjugate gradient (1000 steps) methods. Firstly, the
protein and bilayer were restrained using a potential of 5 kcal mol−1 Å2 and only
solvent and ions were allowed to relax. This was followed by a full minimisation of
the entire systems using steepest descent (5000 steps) and conjugate gradient
(5000 steps) methods.
The systems were heated for 100 ps from 0 to 100 K in the NVT ensemble using
a Langevin thermostat with harmonic restraints of 5 kcal mol−1 Å−2 on the non-
hydrogen atoms of the lipids, protein and lipopeptide. Initial velocities were
sampled from a Boltzmann distribution. Next, the system was heated to 310 K over
300 ps in the NPT ensemble. Equilibration was performed at 310 K and 1 bar in an
NPT ensemble for 100 ns in five steps: (I) the membrane lipid head groups were
allowed to move, while the whole system was restrained using 5 kcal mol−1 Å−2 for
5 ns; (II) the lipid bilayer was allowed to move, while the rest of the system was
restrained using 5 kcal mol−1 Å−2 for 10 ns; (III) the lipid bilayer including water
and ions were allowed to move, while the protein was restrained using 1 kcal mol
−1 Å−2 for 15 ns; and (IV) the whole system was allowed to equilibrate without any
restrains for 70 ns. The final production step of 500 ns was run at 310 K and 1 bar
in the NPT ensemble using the Langevin thermostat and Monte Carlo barostat.
The simulations were performed using a time step of 2 fs. Non-bonded interactions
were cut-off at 10.0 Å and long-range electrostatic interactions were calculated
using PMEMD85,86. The SHAKE algorithm was used to constrain bond lengths87.
Five replica runs of 500 ns MD simulation each were performed for all systems.
The FF14SB88 and Lipid1489 force fields were used in all simulations. The
simulations were performed on Kelvin2 and JADE clusters.
MD simulations trajectory analysis. Trajectory reimaging, root mean square
deviation, root mean square fluctuations, distances, hydrogen bonding, principal
component analysis and cluster analysis were conducted using the AmberTools18
CPPTRAJ package90. Visual molecular dynamics (VMD) was used for visualisation
and movies91. PyMOL and Maestro 2018-4 were used to make images. The
residue–ligand interaction energy was calculated using the ‘namdenergy.tcl’ script
version 1.6 of NAMD 2.1392.
QM/MM adiabatic potential energy calculations. Structures for the QM/MM cal-
culations were obtained from the cluster analysis of production trajectories of Lit in
complex with the lipopeptide substrate and product. The structures were first
subjected to 2000 steps of steepest descent energy minimisation followed by
2000 steps of conjugate gradient minimisation using Amber1878. The lipid bilayer
was excluded in the QM/MM setup, but the water molecules that were present near
the active site from the MD simulations were included. The QM/MM calculations
were performed using the ChemShell suite 201993. All the quantum mechanical
(QM) calculations were performed with the density functional theory (DFT) using
the B3LYP functional with def2-SVP def2/J basis set. The D3 dispersion corrections
with BJ damping were also included in the DFT calculations94–96. The QM cal-
culations was run using the ORCA 4.2.0 package97 and the MM calculations were
computed using the DL_POLY MD simulation package98. The FF14SB force
fields88 were used for the MM calculations. The RIJCOSX approximation with the
TightSCF criteria, Grid4 and GridX4 were used in the QM calculations. The effect
of the protein environment on the polarisation of the QM wave function was
described by the electronic embedding scheme99. The QM region (74 atoms in
total) consists of DAG-Cys, the α-amino group of the cysteine residue and His153
and His85 residues with an overall charge of +2. The residues and water molecules,
which were within 8 Å of the acylated cysteine were allowed to move freely and the
rest of the system was frozen during the geometry optimisation. Hydrogen link
atoms were used to saturate the dangling bonds at the QM region. The reaction
coordinate for the formation of the eight-membered cyclic intermediate (IM2)
starting from the product structure was defined as a linear combination of the
distances d1 and d2 (Supplementary Fig. 16).
The transition sate structures associated with the reaction mechanism of Lit
were obtained by running the minimum energy path calculations using the nudged
elastic band method100,101. The transition state structures were then subjected to
full optimisation using the dimer method102. The transition state structures were
validated by the presence of a single imaginary frequency at 310 K using the
thermal keyword in the ChemShell suite93. The distort keyword was then used to
obtain the corresponding local minima structures connecting the transition states.
Rate constants (kcat) were calculated using the Arrhenius equation at T= 310 K
using a pre-exponential factor derived from transition state theory,
kcat ¼ κðKBT=hÞeðEa=RTÞ ð1Þ
where κ is the reflection coefficient that was set equal to 1, Ea is the activation
energy barrier, R is the gas constant, KB is Boltzmann’s constant, and h is Planck’s
constant103,104.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Atomic coordinates and structure factors have been deposited in the Protein Data Bank
(PDB) with accession codes 7B0O (apo Lit wild-type, monoclinic P21 form), 7B0P (apo
Lit wild-type, orthorhombic P21212 form), 7B0Q (LitH85A, monoclinic C21 form) and
7B0R (LitH85R, monoclinic C21 form). The atomic coordinates of the QM region used in
the QM/MM are available as a Supplementary Dataset 1. Other data supporting the
findings of this manuscript are available from the corresponding author upon reasonable
request. Source data are provided with this paper.
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